← FDA Drug Approvals (Drugs@FDA)

NAPROXEN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: YICHANG HUMANWELL · Approved 2019-08-30

Drug application

FDA Application #
ANDA212033
Application type
Abbreviated New Drug Application (Generic)
Brand name
NAPROXEN SODIUM
Generic name
Naproxen Sodium
Active ingredients
NAPROXEN SODIUM
Dosage form
TABLET
Route
ORAL
Marketing status
Over-the-counter
Sponsor
YICHANG HUMANWELL
First approval
2019-08-30

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown